{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:05:36Z","timestamp":1790827536811,"version":"4.1.0"},"reference-count":100,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ther. Deliv."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.4155\/tde-2016-0022","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T15:07:56Z","timestamp":1468336076000},"page":"495-510","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":33,"title":["Challenges in Nasal Drug absorption: How Far have We come?"],"prefix":"10.1080","volume":"7","author":[{"given":"Remigius U","family":"Agu","sequence":"first","affiliation":[{"name":"Biopharmaceutics & Drug Delivery Lab, College of Pharmacy, 5968 College Street, PO Box 15000, Halifax, NS, B3H 4R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"e_1_3_2_3_1","unstructured":"Markets and Markets Inc. www.marketsandmarkets.com\/Market-Reports\/drug-delivery-technologies-market-1085.html."},{"key":"e_1_3_2_4_1","unstructured":"Presistence Market Research (PMR) . www.persistencemarketresearch.com\/market-research\/intranasal-drug-delivery-market.asp."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAR.0000026823.82950.ff"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.03.003"},{"key":"e_1_3_2_7_1","unstructured":"US FDA . www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/FormsSubmissionRequirements\/ElectronicSubmissions\/DataStandardsManualmonographs\/ucm071667.htm."},{"key":"e_1_3_2_8_1","volume-title":"Neuroscience. 2nd Edition","author":"Purves D","year":"2001","unstructured":"Purves D Augustine GJ Fitzpatrick D et al. The olfactory epithelium and olfactory receptor neurons. In : Neuroscience. 2nd Edition. PurvesDAugustineGJFitzpatrickD (Eds). Sinauer Associates, Sunderland, MA (2001)."},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000377638"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2006.19.301"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.90376.2008"},{"key":"e_1_3_2_12_1","article-title":"Optimization of magnetophoretic-guided drug delivery to the olfactory region in a human nose model","author":"Xi J","year":"2015","unstructured":"Xi J Zhang Z Si XA Yang J Deng W . Optimization of magnetophoretic-guided drug delivery to the olfactory region in a human nose model. Biomech. Model Mechanobiol.www.ncbi.nlm.nih.gov\/pubmed\/26386567 (2015) (Epub ahead of print).","journal-title":"Biomech. Model Mechanobiol."},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/014556139907800814"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348949610500912"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.3.8630555"},{"key":"e_1_3_2_16_1","first-page":"1","volume-title":"Nasal Systemic Drug Delivery","author":"Chien YW","year":"1989","unstructured":"Chien YW Suk SE Chang SF . Anatomy and physiology of the nose. In : Nasal Systemic Drug Delivery. ChienYWSuKSEChangSF (Eds). Marcel and Dekker Inc., NY, USA, 1\u201326 (1989)."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-015-0576-3"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(95)04120-6"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00115-6"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/js950381s"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015904730599"},{"key":"e_1_3_2_22_1","first-page":"261","article-title":"Nasal mucosa as an absorption barrier","volume":"40","author":"Cornaz AL","year":"1994","unstructured":"Cornaz AL Buri P . Nasal mucosa as an absorption barrier. Eur. J. Pharm. Biopharm.40, 261\u2013270 (1994).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"e_1_3_2_23_1","first-page":"213","article-title":"Macromolecular permeability of the tight junction of the human nasal mucosa","volume":"23","author":"Inagaki M","year":"1985","unstructured":"Inagaki M Sakakura Y Itoh H Ukai K Miyoshi Y . Macromolecular permeability of the tight junction of the human nasal mucosa. Rhinol.23, 213\u2013221 (1985).","journal-title":"Rhinol."},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.005769"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/08958378.2015.1066903"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0098-2997(87)90021-5"},{"key":"e_1_3_2_27_1","first-page":"69","article-title":"Enzymatic barriers to peptide and protein absorption","volume":"5","author":"Lee VH","year":"1988","unstructured":"Lee VH . Enzymatic barriers to peptide and protein absorption. Crit. Rev. Ther. Drug Carrier Syst.5, 69\u201397 (1988).","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.2307\/3430682"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.03.025"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2012.636801"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i4.20"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.14.77"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(97)10019-7"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-012-0108-9"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600751113"},{"issue":"2","key":"e_1_3_2_36_1","first-page":"111","article-title":"Deposition pattern of nasal sprays in man","volume":"26","author":"Newman SP","year":"1988","unstructured":"Newman SP Mor\u00e9n F Clarke SW . Deposition pattern of nasal sprays in man. Rhinol.26 (2), 111\u2013120 (1988).","journal-title":"Rhinol."},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2006.19.301"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/08958378.2015.1066904"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.61"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2010.153"},{"key":"e_1_3_2_41_1","article-title":"Design and testing of electric-guided delivery of charged particles to the olfactory region: experimental and numerical studies","author":"Xi J","year":"2015","unstructured":"Xi J Yuan JE Alshaiba M et al. Design and testing of electric-guided delivery of charged particles to the olfactory region: experimental and numerical studies. Curr. Drug Deliv.www.ncbi.nlm.nih.gov\/pubmed\/26362143 (2015) (Epub ahead of print).","journal-title":"Curr. Drug Deliv."},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24937"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics6020249"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872213X09666150531174219"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-006-0071-5"},{"issue":"6","key":"e_1_3_2_46_1","first-page":"30","article-title":"Deposition of intranasal glucocorticoids - preliminary study","volume":"69","author":"Rapiejko P","year":"2015","unstructured":"Rapiejko P Sosnowski TR Sova J Jurkiewicz D . Deposition of intranasal glucocorticoids - preliminary study. Otolaryngol. Pol.69 (6), 30\u201338 (2015).","journal-title":"Otolaryngol. Pol."},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90403-2"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2005.07.009"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2006.08.017"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2009.01.029"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1208\/ps010313"},{"issue":"9","key":"e_1_3_2_52_1","first-page":"400","article-title":"Mucoadhesive drug delivery systems: a review of current status","volume":"37","author":"Chowdary KP","year":"2000","unstructured":"Chowdary KP Srinivas L . Mucoadhesive drug delivery systems: a review of current status. Indian Drugs.37 (9), 400\u2013406 (2000).","journal-title":"Indian Drugs."},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.01.010"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.05.003"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9488-9"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357011775145"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.3.4.529"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.3109\/10611869808997878"},{"key":"e_1_3_2_59_1","first-page":"1","volume-title":"Peptide and Protein Drug Delivery. Advances in Parenteral Sciences\/4","author":"Lee VHL","year":"1991","unstructured":"Lee VHL . Changing needs in drug delivery in the era of peptide and protein drugs. In : Peptide and Protein Drug Delivery. Advances in Parenteral Sciences\/4. Marcel Dekker, Inc., NY, USA, 1\u201356 (1991)."},{"key":"e_1_3_2_60_1","first-page":"s78","article-title":"A possible mechanism of absorption promotors","volume":"6","author":"Yata N","year":"1983","unstructured":"Yata N Higashi Y Murakami T et al. A possible mechanism of absorption promotors. J. Pharm. Dyn.6, s78 (1983).","journal-title":"J. Pharm. Dyn."},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.19.2.103"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(81)90013-X"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9307-4"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00030-7"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-004-9013-3"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018911206646"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600680942"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510060411"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2013.08.029"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600821124"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.1.1.49"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.1.2.159"},{"issue":"7","key":"e_1_3_2_73_1","article-title":"Development of nasal delivery systems: a review","volume":"2","author":"Aurora J","year":"2002","unstructured":"Aurora J . Development of nasal delivery systems: a review. Drug Dev. Deliv.2 (7), (2002). http:\/\/drug-dev.com\/Main\/Back-Issues\/Development-of-Nasal-Delivery-Systems-A-Review-489.aspx.","journal-title":"Drug Dev. Deliv."},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(97)00193-4"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018908705446"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(87)90216-X"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/02652040500098960"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.01.007"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.05.008"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20718"},{"key":"e_1_3_2_81_1","first-page":"112","volume-title":"Drug Absorption Studies. In Situ, In Vitro and In Silico Models","author":"Agu RU","year":"2008","unstructured":"Agu RU Ugwoke MI . In situ and ex vivo nasal models for preclinical drug development studies. In : Drug Absorption Studies. In Situ, In Vitro and In Silico Models. EhrhardtCarstenKimKwang-Jin (Eds), 112\u2013134 (2008)."},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-004-0018-0"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(97)00061-6"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2015.11.062"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00103"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.741589"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016210231121"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357011777981"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(02)00039-X"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(97)00253-8"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2004.02.019"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.12.037"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2012.01.015"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2012.01540.x"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2009.08.008"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-014-1494-0"},{"key":"e_1_3_2_97_1","doi-asserted-by":"crossref","unstructured":"K\u00fcrti L Veszelka S Bocsik A et al. Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells a model for nasal epithelial permeability Cytotechnology 65 (3) 395\u2013406 (2013).","DOI":"10.1007\/s10616-012-9493-7"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1177\/0003489414565003"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016038119909"},{"key":"e_1_3_2_100_1","unstructured":"US FDA . https:\/\/clinicaltrials.gov\/."},{"key":"e_1_3_2_101_1","volume-title":"Access Medicine","author":"Sliva S","year":"2010","unstructured":"Sliva S Barton E . Intranasal Use of Drugs in the Emergency Room and Pre-Hospital Arenas. Access Medicine, McGraw-Hill (2010). www.medscape.com\/viewarticle\/730093_print."},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2009.01.002"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/tde-2016-0022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:57:09Z","timestamp":1715972229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/tde-2016-0022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.4155\/tde-2016-0022"],"URL":"https:\/\/doi.org\/10.4155\/tde-2016-0022","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}